Septinta SRL
The score of Septinta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Septinta's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 55,020 € | ||||
| Equity | 148,715 € | ||||
| Cash | 177,422 € | ||||
| EBITDA | 78,700 € | ||||
| Total assets | 213,760 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Septinta's financial analysis
- Solvency69.6%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Septinta
Septinta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0807.720.582
- VAT number
- BE0807720582
- Peppol
- Registered · 0208:0807720582 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Nov 2008
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Septinta (SRL) has been based in Waterloo since 2008, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 55,020 € and equity of 148,715 €; its revenue is not published. Its solvency stands at 69.6%, above the median of its sector (43.9%).
Companies similar to Septinta
Companies in the same business, of comparable size and area, outside its group.
- AB2 Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet 278,131 €
- Science ET Medecine Wholesale of pharmaceutical and medical goods Waterloo · balance sheet 127,922 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
Frequently asked questions about Septinta
What is the revenue of Septinta?
Septinta files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Septinta?
In Belgium, the VAT number is the company number prefixed with BE: BE0807720582 for Septinta, if the company is VAT-registered. Its company number (CBE) is 0807.720.582.
Where is the registered office of Septinta?
According to the CBE register, the registered office of Septinta is in 1410 Waterloo.
What is the equity of Septinta?
At the close of the 2025 financial year, the equity of Septinta amounts to 148,715 €, a solvency of 69.6% of total assets.
Who manages Septinta?
The register lists 4 active mandates at Septinta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Septinta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →